Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Fotios Asimakopoulos"'
Autor:
Jing Zhang, Marta Chesi, P. Leif Bergsagel, Quinlan Furumo, Evan Flietner, Grant Yun, Yun Zhou, Mei Yu, Zhi Wen, Erik A. Ranheim, Robert Burns, Fotios Asimakopoulos, Remington Finn, Natalie S. Callander, Demin Wang, Adhithi Rajagopalan
Publikováno v:
Blood. 132:1006-1006
Multiple myeloma (MM) is characterized by clonal expansion of malignant plasma cells (PCs) and aberrant production of monoclonal immunoglobulin detected as an M spike using serum protein electrophoresis. In the United States, MM represents ~15% of he
Autor:
Zhi Wen, Natalie S. Callander, P. Leif Bergsagel, Poulikos I. Poulikakos, Athanasios Papadas, Marta Chesi, Evan Flietner, Fotios Asimakopoulos, Zachary Morrow, Adam Pagenkopf, Jing Zhang, Alexander Cicala, Adhithi Rajagopalan
Publikováno v:
Blood. 132:4480-4480
Background and Aims. Despite the fact that the myeloma mutational landscape was elucidated several years ago, there are yet no approved precision therapies targeting specific driver mutations. The role of common, but somewhat enigmatic, mutational ev
Publikováno v:
Journal of Neurology. 249:1746-1748
Autor:
Eliot C. Williams, Natalie S. Callander, Stephanie Markovina, Shigeki Miyamoto, Jill M. Kolesar, Michael A. Thompson, KyungMann Kim, Fotios Asimakopoulos, Andrew T Humbert, Thomas McFarland, Ronald S. Go, Rachel J Cook
Publikováno v:
Blood. 120:5041-5041
Abstract 5041 Introduction: Angiogenesis as an important feature of malignant propagation in MM and other malignancies. This had led to the development of treatment strategies focused on inhibition of vascular growth. Bevacizumab (B) has previously b
Autor:
Fotios Asimakopoulos, Harold Varmus
Publikováno v:
Blood. 108:243-243
Multiple myeloma (MM) and related plasma cell dyscrasias are characterized by monoclonal expansion of terminally differentiated plasma cells. However, it is puzzling how the quiescent plasma cell can be the source of often aggressive and relapsing ne